A licensing agreement between the CIGB
and Abivax for the development and commercialisation of the therapeutic vaccine against Hepatitis B, stated Arteaga.
CIGB said more than 81,000 diabetes patients are using Heberprot-P around the world, and that the medication has already been patented in 40 Latin and Asian countries.
CIGB expects annual global revenues for Heberprot-P to reach $100 million for 2012.
He said that the money would fund research projects of CIGB
, in collaboration with other Cuban research centres, which are aimed at developing new drugs or a vaccine against AIDS.
Azpillaga told the newspaper that he personally visited the secret laboratories while delivering a package to the CIGB
Gerardo Guillen, PhD, head of R&D at CIGB
in Havana, commented: "This first-in class therapeutic vaccine is awaiting market approval in Cuba and we are very pleased to see the great progress our partner Abivax is making with the international development of this world leading immunotherapeutic to treat chronic hepatitis B.
This has led to the important deals that we have with the CIGB
and the Finlay Institute, which are central to ABIVAX' strategy to become a global leader in the anti-virals and vaccines.
Borroto told reporters the harvest of that corn will provide enough seeds to sow another 12,000 acres, and that phase will be undertaken once the CIGB
obtains authorization from other government agencies.
That figure comes mainly from the vaccine against Hepatitis B, star of the CIGB
products, interferon, antiviral and other drugs.
It's used in the process of purifying the active ingredient of the Hepatitis B vaccine produced in Cuba by CIGB
and sold under the trademark Heberbiovac-HB.
Competitive Assessment 50 Leading players reviewed 3SBio Actavis Amgen Avesthagen Bioclones Biocon Biogen Idec Biolex Therapeutics BioPartners Bioton Boehringer Ingelheim Cangene Cell Therapeutics Celltrion CIGB
Cinnagen Cipla CJ Corp Claris Lifesciences Dr Reddy's Elona Biotechnologies Gennova Biopharmaceuticals Getz Pharma GTC Biotherapeutics Hospira Inno Biologics Intas Biopharmaceuticals Itero Biopharmaceuticals LG Life Sciences Merck & Co MJ Biopharma Momenta Pharmaceuticals Mycenax Biotech Mylan Pfizer Protalix Reliance Life Sciences Samsung Sandoz SciGen Selexis Shantha Biotechnics Simcere/Shanghai Celgen Stada Arzneimittel Teva Pharmaceutical Industries Three Rivers Pharmaceuticals Viropro Watson Wockhardt Zenotech Laboratories
Global Bioscience Partnership: Alsace Development International, APBio, AusBiotech, BayBio, BC Biotech, BIA, BioAlberta, BIOCOM, BioMelbourne Network, BioNova, BIOQuebec, BIO-SA, BIOTECanada, Biotech Consortium India Limited, CIGB
, CIMAB S.